NASDAQ NMS - GLOBAL MARKET · IMA
-1.10% · -$0.0650 · Vol 1.6K
Live · updated 11:34:14 ET
ImageneBio Inc

ImageneBio Inc

Pharmaceuticals
$5.86
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is IMA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About ImageneBio Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2025
Employees
17
Country
US

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.94
Day high
$5.94
Day low
$5.86
Previous close
$5.92
52W high
$6.07
-3.46% from high
52W low
$5.51
62% of range
Market cap
$66.8M
EPS
$-16.2600
Shares out
11.3M
Volume
1.6K
VWAP
$5.83
Price history computed in-house
1W
+0.51%
1M
+6.26%
SMA 50 $5.82 · above
SMA 200 $5.82 · above
52W position 62%
Veridion warehouse edge

Warehouse intelligence for IMA.

Veridion Score
63
0: 951: 392: 683: 204: 715: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

IMA insider activity

ImageneBio Inc

Score
Coverage building
Pressure
Net buying
Filings
1
Buys / sells
1 / 0
Net value
$96K
Insiders
1
Named filers
SP
SLATTERY JOSEPH P
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net buying: $96K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2025-12-292025-12-24SLATTERY JOSEPH PInsiderbuy$5.9916,00016,000$96KSEC Form 4
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

IMA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IMA in this window.
Lobbying spend

IMA lobbying filings, year to date.

Registered lobbying filings matched to ImageneBio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IMA in this window.
Latest news · IMA
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for IMA.
Options
Sovereign unlock shows live options positioning for IMA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.